764
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Strategic considerations under the Biologics Price Competition and Innovation Act

, JD MBA PhD &
Pages 915-918 | Published online: 06 Jul 2013

Figures & data

Figure 1. Schematic illustrating the ‘Volley Phase’ of document exchanges between biosimilar applicant and reference product sponsor.

Figure 1. Schematic illustrating the ‘Volley Phase’ of document exchanges between biosimilar applicant and reference product sponsor.

Figure 2. Schematic illustrating the “Negotiation Phase” between biosimilar applicant and reference product sponsor.

Figure 2. Schematic illustrating the “Negotiation Phase” between biosimilar applicant and reference product sponsor.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.